7 mei 2026 · 14:56

OpenBind Open AI Drug Discovery Data: What It Means

The UK-led OpenBind initiative has published its first open AI model and large-scale drug-protein binding dataset, lowering the barrier for every biotech and academic lab that runs drug discovery workloads. This episode also covers Microsoft's internal debate over its 2030 renewable energy pledge, a Wall Street semiconductor rally built on AI spending, and a Samsung smartwatch that predicts fainting five minutes early. All stories carry direct consequences for European professionals.